Review of Evidence for Treatment of Methamphetamine Use Disorder | October 13, 2022
Date of Presentation: October 13, 2022
Type: Past Presentation
Audience: Clinical Community
Keywords: #contingency #contingency management #meth #methamphetamine #MUD #psychosocial #stimulant #SUD #use disorder
In this presentation, Dr. Jasen Christensen, DO, provides an overview of the existing evidence for treatment and management of methamphetamine use disorder (MUD). Dr. Christensen describes the strength of evidence for psychosocial interventions with a particular focus on contingency management.
Recording:
Presented by:
Dr. Jasen Christensen, DO
Jasen Christensen, DO, received undergraduate degrees in Cellular/Molecular Biology and German Language from Humboldt State University (now Cal Poly Humboldt) in 1999. He earned the degree of Doctor of Osteopathic Medicine at Western University of Health Sciences in 2006. He completed a residency in psychiatry at the University of New Mexico in 2010. His past work in psychiatry has included positions with the US Public Health Service (at an IHS service unit), inpatient and PES at a county psychiatric hospital, and integrated psychiatry at a community health center (FQHC). He is board certified in psychiatry and addiction medicine.
Resources Provided:
- Treatment of Stimulant Use Disorders (SAMHSA)
- Contingency Management for Substance Abuse Treatment, A guide to implementing this evidence-based practice (Routledge)
- Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness
- Contingency management (CM) project (WA State)
- Contingency Management (Prism)
- A review of contingency management for the treatment of substance-use disorders (PubMed)
- Contingency Management as a Tool for Alcohol Use Disorders among American Indian and Alaska Native People (WSU)
- Contingency management for stimulant use disorder - On-line Course (WSU)
- Mirtazapine to reduce methamphetamine use: a randomized controlled trial
- Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial
- Bupropion for the treatment of methamphetamine dependence
- Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
- Bupropion and Naltrexone in Methamphetamine Use Disorder
- Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
- Pharmacotherapy for Stimulant-Related Disorders
- Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder
- Recovery Incentives: California's Contingency Management Program
- Pharmacist Toolkit: Methamphetamine Use Disorder
Date added: October 13, 2022